Download eBook for Free

FormatFile SizeNotes
PDF file 3.2 MB

Use Adobe Acrobat Reader version 10 or higher for the best experience.

This study aimed to inform Hepatitis C (HCV) treatment by (1) better understanding the nexus of factors physicians consider when making HCV treatment decisions; (2) investigating the comparative influence and importance of specific factors and the trade-offs implicated in the decisionmaking process; and (3) examining how much thrombocytopenia impacts treatment decisions and how it impacts treatment.

To meet this goal, we conducted five analyses, focusing on four European countries characterised by different approaches to healthcare organisation and financing, which alongside cultural differences may have potential implications for treatment pathways for patients with HCV infection. These were: France, Italy, Spain, and the United Kingdom. These analysis included:

  1. Review the academic literature and of relevant national and European guidelines;
  2. Conduct key informant interviews (KIIs) with national experts to contextualise the data from the literature review and further explore some emerging themes;
  3. Map the patient journey in the four countries to identify stages HCV patients pass through once they have entered the healthcare system and map, for each stage, potential points of departure from the typical journey;
  4. Design and conduct of Discrete Choice Experiments (DCEs) to quantitatively assess the importance of factors that influence treatment decisions;
  5. Conduct expert workshop to help build scenarios identifying challenges to HCV treatment.

The five analyses build on one another, with the first three providing evidence that fed into the design of the DCEs and with the DCE results in turn serving as the key inputs into building the scenarios for the expert workshop.

Table of Contents

  • Chapter One


  • Chapter Two

    Our methodological approach

  • Chapter Three

    Literature review identifying the diversity of factors influencing treatment decisions

  • Chapter Four

    Key informant interviews identifying and understanding the factors influencing treatment decisions

  • Chapter Five

    Mapping patients' journeys for HCV treatment

  • Chapter Six

    Using discrete choice experiments to quantify physicians' treatment decisions

  • Chapter Seven

    Using scenario building to explore future potential situations

  • Chapter Eight


  • Appendix A

    Literature review search strategy

  • Appendix B

    Internal key informant interview guide (for interviewer)

  • Appendix C

    Profile of interviewees

  • Appendix D

    Workshop agenda

  • Appendix E

    Full discrete choice experiment questionnaire

Research conducted by

The research described in this report was conducted by RAND Europe.

This report is part of the RAND Corporation Research report series. RAND reports present research findings and objective analysis that address the challenges facing the public and private sectors. All RAND reports undergo rigorous peer review to ensure high standards for research quality and objectivity.

This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.